Option Care Health’s (OPCH) “Market Outperform” Rating Reaffirmed at JMP Securities

Option Care Health (NASDAQ:OPCH)‘s stock had its “market outperform” rating reaffirmed by analysts at JMP Securities in a research note issued to investors on Friday,Benzinga reports. They presently have a $30.00 target price on the stock, down from their previous target price of $31.00. JMP Securities’ price objective would suggest a potential upside of 25.05% from the company’s previous close.

Several other brokerages also recently commented on OPCH. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Barrington Research lowered their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Truist Financial lowered their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $29.14.

Option Care Health Trading Down 0.6 %

Shares of OPCH opened at $23.99 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63. The firm has a market cap of $4.08 billion, a price-to-earnings ratio of 20.16, a PEG ratio of 2.43 and a beta of 1.31. The business’s fifty day moving average is $23.10 and its 200-day moving average is $27.70.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 0.64% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Wellington Management Group LLP raised its stake in Option Care Health by 15.5% during the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after buying an additional 1,328,326 shares during the last quarter. FMR LLC grew its holdings in Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP raised its position in shares of Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares in the last quarter. State Street Corp lifted its stake in shares of Option Care Health by 1.4% in the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after purchasing an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans boosted its position in shares of Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after purchasing an additional 404,811 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.